HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetic susceptibility to myocardial infarction and coronary artery disease.

Abstract
Atherosclerotic involvement in the coronary arteries, which can result in heart attack and sudden death, is a common disease and prototypic of a complex human trait. To understand its genomic basis, eight linkage studies of sibling pairs have been performed. Although there was limited inter-study concordance of important loci, two gene variants in the leukotriene pathway (ALOX5AP and LTA4) have emerged as susceptibility factors for myocardial infarction (MI). Genome-wide association studies have also been undertaken, and the pro-inflammatory cytokine lymphotoxin-alpha (LTA), and its key ligand galectin-2 (LGALS2) have been identified as genes implicated in predisposition for heart attack. By cueing into the genomic basis for low serum LDL cholesterol levels, much work has been done to advance the importance of the serine protease PCSK9, which modulates LDL receptor function. Lifelong lowered LDL cholesterol associated with PCSK9 point mutations in 2-3% of individuals have been shown to provide marked protection from coronary artery disease (CAD). Most of the success in this field has been with the phenotype of MI, which is considerably more restrictive than CAD. Four principal and interdependent processes--lipoprotein handling, endothelial integrity, arterial inflammation, and thrombosis--have been supported as important via the clustering of genes, thus far implicated in CAD susceptibility. Of note, connecting genes in a single pathway (leukotriene), of a protein and its ligand (LTAalpha) or from one disease to another [age-related macular degeneration (AMD); complement factor H (CFH)], or even three disease characterized by inflammation (MHC2) have now been reported. Although the population attributable risk for any of the genes identified to date is limited, such discovery is likely to be accelerated in the future.
AuthorsEric J Topol, Jonathan Smith, Edward F Plow, Qing K Wang
JournalHuman molecular genetics (Hum Mol Genet) Vol. 15 Spec No 2 Pg. R117-23 (Oct 15 2006) ISSN: 0964-6906 [Print] England
PMID16987874 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • 5-Lipoxygenase-Activating Proteins
  • ALOX5AP protein, human
  • Carrier Proteins
  • Galectin 2
  • Leukotriene A4
  • Lipoproteins, LDL
  • Lymphotoxin-alpha
  • Membrane Proteins
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Serine Endopeptidases
Topics
  • 5-Lipoxygenase-Activating Proteins
  • Carrier Proteins (genetics)
  • Coronary Artery Disease (genetics, metabolism, pathology)
  • Female
  • Galectin 2 (genetics)
  • Genetic Linkage
  • Humans
  • Leukotriene A4 (genetics)
  • Lipoproteins, LDL (blood)
  • Lymphotoxin-alpha (genetics)
  • Male
  • Membrane Proteins (genetics)
  • Models, Cardiovascular
  • Models, Genetic
  • Myocardial Infarction (genetics, metabolism, pathology)
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Serine Endopeptidases (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: